공시 • May 15
Newtopia Inc. announced that it has received CAD 1.6 million in funding Newtopia Inc. announced that it has received CAD 1.6 million in new senior secured debt financing om May 14, 2025. 공시 • Aug 28
Newtopia Inc., Annual General Meeting, Nov 08, 2024 Newtopia Inc., Annual General Meeting, Nov 08, 2024. 공시 • Aug 01
Newtopia Inc. to Report Q2, 2024 Results on Aug 08, 2024 Newtopia Inc. announced that they will report Q2, 2024 results After-Market on Aug 08, 2024 공시 • May 24
Newtopia Inc. to Report Q1, 2024 Results on May 23, 2024 Newtopia Inc. announced that they will report Q1, 2024 results After-Market on May 23, 2024 공시 • Mar 01
Newtopia Inc. announced that it has received CAD 0.7465 million in funding Newtopia Inc. a brokered private placement of 14,430,000 units at a price of CAD 0.05 per unit for gross proceeds of CAD 721,500; and a non-brokered private placement of 500,000 units at a price of CAD 0.05 per unit for gross proceeds of CAD 25,000; for aggregate gross proceeds of CAD 746,500 on February 29, 2024. The transaction included participation from Jeff Ruby, CEO of the company; Roger Poirier and Hugh G. McCauley for an aggregate of 1,110,000 units. Each unit is comprised of one common share and one common share purchase warrant. Each warrant is exercisable to acquire one common share at an exercise price of CAD 0.10 per common share, subject to adjustments in certain events, until March 1, 2027. No fees or commissions are payable to the agent in connection with the non-brokered offering. A finder acting in connection with the non-brokered offering received a finder's fee in the aggregate total amount of CAD 1,250 and an aggregate of 25,000 finder's warrants exercisable for common shares on substantially the same terms as the broker warrants. In consideration for the services provided by the agent in connection with the brokered offering, the agent received a cash fee in the aggregate amount of CAD 38,675 and 721,000 non-transferable broker warrants. Each broker warrant is exercisable for one common share at the offering price, subject to adjustments in certain events, until March 1, 2026. All securities issued in connection with the offerings are subject to a hold period which will expire on June 30, 2024, the date that is four months and one day from the closing of the offerings. The offerings are subject to final acceptance of the TSX Venture Exchange. 공시 • Jan 29
Newtopia Launches "Glp-1 Sustain" Program to Affordably Preserve and Extend Valuable Health Benefits of Novel Weight Loss Drugs Newtopia Inc. announced GLP-1 Sustain, a companion program to specifically support and extend the dramatic clinical outcomes produced by glucagon-like-peptide-1 (GLP-1) receptor agonists and other related agonist drugs at a critical juncture in the patient journey - once a user first encounters a "weight loss plateau"i and even if users cease taking the medication entirely. In so doing, Newtopia'sGLP-1 Sustain brings to market a much-needed pathway to ensure that the many short-term health benefits of these medications may be long-lasting and that the significant costs to invest in them may in fact yield a positive ROI for payers, employers, value-based providers, and patients. Newtopia's habit change platform is already proven for its unrivaled ability to generate and maintain high levels of user-engagement for periods of two years and beyond. Newtopia leads the industry by consistently demonstrating 70% of its participants as actively engaged at 12 months, and over 60% engaged at 24 months. Through its unique engagement capabilities, Newtopia cultivates positive lifestyle habits among its participants focused on nutrition, exercise, and emotional well-being. According to published results of a randomized controlled clinical trial (RCT) on 2,835 individuals with increased waist circumference and at least one other metabolic risk factor, Newtopia's method for habit change produces significant beneficial change in several metabolic risk factors and an average weight loss of 10 pounds or 4.3% of the pre-program weight. Unpublished data from the three-year RCT further indicate that the program's weight loss benefit persists for at least three years. Such durable clinical benefits lead to an annual cost savings of at least $1,464 per participant. Leveraging this very same habit change platform, Newtopia'sGLP-1 Sustain combines genetic testing for risk factors and key behaviors with individualized live coaching, curated content, and remote monitoring from smart devices to help any GLP-1 user identify, develop, and internalize constructive lifestyle habits necessary to sustain weight loss, health, and well-being over time – whether users remain on, or ultimately stop taking these medications. GLP-1 Sustain will also produce significant annual cost savings for Newtopia clients of ~$10,000+ per participant (i.e. the average annual cost of GLP-1 medications of ~$12,000 replaced post-plateau, or if users cease the medication, with the average annual value-based cost of Newtopia of ~$750). At less than 1/10th the cost of these drugs, GLP-1 Sustain offers a proven, scalable, and affordable pathway to preserve the weight loss and other health benefits produced by GLP-1 medications for millions of Americans. 공시 • Nov 10
Newtopia Inc. to Report Q3, 2023 Results on Nov 16, 2023 Newtopia Inc. announced that they will report Q3, 2023 results After-Market on Nov 16, 2023 공시 • Oct 17
Newtopia Inc. announced that it has received CAD 0.805 million in funding On October 16, 2023, the company announced that it has received CAD 425,000 in its second tranche. The securities issued pursuant to the offering are subject to a four month hold period that expires on February 14, 2024. The debentures issued in connection with this second tranche of the offering will mature on October 13, 2024. The company paid a finder's fee of CAD 1,800 and 15,652 non-transferable compensation options. Each compensation option is exercisable into one common share at CAD 0.115 per share, subject to adjustments in certain events, until October 13, 2025. 공시 • Aug 05
Newtopia Inc. to Report Q2, 2023 Results on Aug 09, 2023 Newtopia Inc. announced that they will report Q2, 2023 results After-Market on Aug 09, 2023 공시 • Jun 29
Newtopia Inc. announced that it expects to receive CAD 0.5 million in funding Newtopia Inc. announced a non-brokered private placement of 13% 50 units of Subordinated Non-Convertible debentures at a price of CAD 10,000 for the gross proceeds of CAD 0.5 million on June 27, 2023. Each unit will be comprised of CAD10,000 principal amount of subordinated and postponed secured non-convertible debentures of the company and bonus shares. In the event that the maximum amount of debentures are issued in connection with the offering, a maximum of 1,538,461 bonus shares will be issuable in connection with the offering. The debentures will mature on the date that is 24 months from the closing date of the offering and are secured by the assets of the Company and bear interest at a rate of 13% per annum payable quarterly in arrears in cash. The company will pay to the holders of the debentures an annual work and credit maintenance fee of 2% of the principal amount in cash. The debentures and the bonus shares to be issued pursuant to the offering, will be subject to a hold period of four months plus one day from the closing date. The offering is subject to approval by the TSXV and the consent of the company's Schedule I bank secured lender. 공시 • Jun 03
Newtopia Inc. announced that it has received CAD 0.0075 million in funding Newtopia Inc. announced that it has received a private placement of 100,000 Shares at a price of CAD 0.075 for the gross proceeds of CAD 7,500 on June 1, 2023. The transaction included participation form individual investor McCauley. After the transaction McCauley owns and controls approximately 13,994,500 Shares and 1,000,000 common share purchase warrants representing 10.0% of the shares on a partially diluted basis. 공시 • May 25
Newtopia Inc. to Report Q1, 2023 Results on May 30, 2023 Newtopia Inc. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 30, 2023